Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.
Clinical trial NCT04737382 · UNKNOWN
Trial details
- NCT number
- NCT04737382
- Sponsor
- The Netherlands Cancer Institute
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-22
- Primary completion
- 2024-08-22
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.